|
© 2006 American Academy of Neurology Brief Communications Genetic heterogeneity in paroxysmal nonkinesigenic dyskinesiaFrom the Division of Neurology (S.D.S., A.J.S., G.-Y.R.H.), Brain Research Center (S.D.S., A.J.S., G.-Y.R.H.), Michael Smith Laboratories (S.D.S., P.J.A., P.C.P.L., L.A.M., T.P.S.), University of British Columbia, Vancouver, BC, Canada; iCAPTURE Centre (G.-Y.R.H.), St. Paul's Hospital, University of British Columbia, BC, Canada. Address correspondence and reprint requests to Dr. Sian Spacey, Neurology and Neurogenetics, Room S-127, 2211 Wesbrook Mall, UBC Hospital, Vancouver, BC V6T 2B5, Canada; e-mail: spacey{at}interchange.ubc.ca Paroxysmal nonkinesigenic dyskinesia (PNKD) is characterized by attacks of dystonia or chorea lasting minutes to hours. Recently, mutations in the myofibrillogenesis regulator 1 gene (MR-1) have been identified in 10 unrelated PNKD kindreds. The authors describe a Canadian PNKD family who does not have mutations in the MR-1 gene and links to a separate locus at 2q31. This indicates that there are at least two different genes responsible for PNKD.
Dr. Spacey is supported by the Vancouver Coastal Health Authority Clinician-Scientist Award and Dr. Snutch is supported by a CIHR Senior Scientist Award. Disclosure: The authors report no conflicts of interest. Received August 18, 2005. Accepted in final form March 2, 2006.
This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||